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1. Introduction 
ABSTRACT 
Purpose: To determine the frequency and factors associated with the presence ofT2 shine-through effect 
in hepatic hemangiomas on diffusion-weighted (DW) magnetic resonance (MR) sequences. 
Materials and metlwds: This retrospective study was approved by institutional review board with waiver 
of informed consent. One hundred forty-nine consecutive patients with 388 hepatic hemangiomas who 
underwent a li ver MR between january 2010 and November 2011 were included. MR analysis evaluated 
the lesion characteristics (signal intensities and enhancement patterns (classical, rapidly filling, delayed 
filling)), the presence ofT2 shine-through effect on DW sequences (b values ofü, 150, and 600 s/mm2 ), 
and apparent diffusion coefficient (ADC) values. Multivariate analysis was performed to study the factors 
associated with the T2 shine-through effect. 
Results: T2 shine-through effect was observed in 204/388 (52.6%) of hepatic hemangiomas and in 100 
(67.1 %) patients. Mean ADC value of hemangiomas with T2 shine-through effect was significantly lower 
than hemangiomas without (2.0 ± 0.48 vs 238 ± 0.45, P< .0001). On multivariate analysis, high signal 
intensity on fat-suppressed T2-weighted fast spin-echo images, hemangiomas with classical or delayed 
enhancement, and the ADC of the li ver were the only significant factors associated with T2 shine-through 
effect. 
Conclusion: T2 shine-through effect is commonly observed in hepatic hemangiomas and is related to 
hemangiomas characteristics. Radiologists should be aware of this phenomenon which could lead to 
misdiagnosis. Jts presence should not question the diagnosis of hemangiomas when typical MR findings 
are found. 
© 2013 Elsevier Ireland Ltd. Ali rights reserved. 
Hepatic hemangiomas are the most common benign hepatic 
tumors and their prevalence ranges from 0.4 to 20% [ 1,2 ]. Hepatic 
hemangiomas are commonly found incidentally at routine radio-
logie examinations such as sonography and computed tomography 
(CT) [2,3 ]. MR imaging is indicated for lesion characterization when 
sonography or CT are inconclusive or when liver lesions are seen 
in patients with chronic liver disease or in oncologie patients. MR 
imaging has been shown as the best imaging modality for diagnos-
ing hepatic hemangiomas with high sensitivity and specificity (84% 
and 100%, respectively) [4]. Typical hemangiomas are hypointense 
on T1-weighted MR images a.nd markedly hyperintense on T2-
weighted images. On contrast-enhanced images, they demonstrate 
early peripheral nodular enhancementwith progressive centripetal 
enhancement on subsequent images [2,5 ]. MR imaging is also help-
ful for diagnosing atypical hemangiomas [G-8]. 
Diffusion-weighted (DW) MR images are useful for characteriz-
ing focal hepatic lesions and can help to distinguish between benign 
and malignant lesions [9,10]. Then a lesion can be considered 
benign (mostly cyst and hemangioma) if the lesion is hyperintense 
on T2-weighted images and on DW images at b = O s/mm2 , with a 
strong signal intensity decrease at high b values and an AOC that 
is subjectively higher than that of the liver [9]. Using these criteria, 
Parikh et al. showed that the overall accuracy of DW images was 
slightly better than that ofT2-weighted images [9]. 
Abbreviations: DW, diffusion-weighted; MR, magnetic resonance; AOC, appar-
ent diffusion coefficient; CT, computed tomography; ROI, region of interest. 
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It is commonly considered that white most hepatic heman-
giomas typically show suppression ofhigh signal intensity at high b 
values (i.e. 500-750 s/mm2 ), some may demonstrate residual high 
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Fig. 1. Flowchart illustra tes patient se!ection. MRI = MR imaging, HH = hepatic 
hemangioma. 
signal intensity on high b value images and are therefore diffi-
cult to characterize with visual assessment of the OW MR images 
[ J 0, 11 ]. This phenomenon is called T2 shine-through effect and was 
first observed in brain diffusion imaging, more particularly in the 
evaluation of a eu te cerebral ischemia [ 12 ]. lt is attributed to the 
contribution ofT2 hyperintensity on the overall signal intensity of 
OW MR images. Indeed, signal intensity of OW MR images is com-
posed ofmixed contributions from the intrinsicT2 properties of the 
tissue being examined, the AOC, and to a lesser degree, of the spin 
density [ 12 j. T2 shine-through effect may occasionally be encoun-
tered in benign liver tumors, but little is known about this effect in 
hepatic hemangiomas [1 O]. 
Thus, the purpose of this study was to determine the frequency 
and associated factors ofî2 shine-through effect in a large series of 
patients with hepatic hemangiomas. 
2. Materials and methods 
This retrospective single-center study was conducted in a ter-
tiary hospital for abdominal diseases and was approved with a 
waiver of informed consent by the institutional review board of 
the same hospital. 
2.1. Study design 
Patients identified in the database of the tertiary hospital men-
tioned above for MR imaging reports who underwent MR imaging 
of the liver with a OW sequence between january 2010 and 
November 2011 and who had at least one hepatic hemangioma 
measuring at least 5 mm in minimum diameter were included. OW 
sequences were performed as part of our routine liver imaging 
protocol. 
A total of 1632 patients were identified. One thousand four 
hundred eighty-three patients were excluded for the following rea-
sons: no lesion suggesting hepatic hemangioma (n = 1420), hepatic 
hemangioma measuring Jess than 5 mm in diameter (n = 15), 
hepatic hemangioma with follow-up imaging ofless than 6 months 
(n = 22), no OW sequences on the picture archiving and commu-
nication system (n=26) (Fig. 1). On the basis ofthese criteria, the 
final study population included 149 patients (mean age, 52.5 years; 
range, 22-84 years) with 388 hemangiomas and of the se, 7 4 ( 49. 7%) 
were women (mean age, 50.6 y~iirs; range, 24-84 years) and 75 
(50.3%) were men (mean age, 54.3 years; range, 22-78 years). 
Hepatic hemangiomas were solitary in 67 patients (45%) and 
multiple in 82 (55%); there were 2 lesions in 30 patients, 3 lesions 
in 21 patients, 4 lesions in 10 patients, 5 lesions in 7 patients and 6 
or more lesions in 14 patients. 
2.2. Reference standard 
Oiagnosis of hemangiomas was established based on a combi-
nation of typical imaging features and follow-up imaging showing 
at least 6 months of stability or on histological analysis. MR imaging 
features were considered for the diagnosis ofhemangioma [ 5,6, l 3 ]: 
well demarcated and notably hyperintense on heavily T2-weighted 
images, and (a) peripheral globular discontinuous enhancement 
over time on contrast-enhanced dynamic images with progres-
sive and centripetal enhancement; or (b) immediate homogeneous 
enhancement and iso or hyperintensity compared with surround-
ing liver parenchyma at the equilibrium phase. 
Three hundred seventy-seven hemangiomas met these crite-
ria (97.2%). Ali hepatic hemangiomas remained stable over time. 
Because some of our patients had previous MR examinations, the 
median follow up period was 18.6 months (range 6-81 months). 
The remaining hepatic hemangiomas (11/388, 2.8%) did not 
meet the imaging criteria and the diagnosis required histologie 
confirmation which was obtained by means of biopsy. Eight 
hemangiomas were isointense on T2-weighted images and three 
hemangiomas did not enhance on contrast-enhanced sequences. 
2.3. MR imaging 
Patients were examined with a 1.5-T superconducting MR sys-
tem using a phased-array surface coi! for signal reception. The 
protocol included a T2-weighted fast spin-echo sequence with 
spectral fat saturation and a T2-weighted single-shot sequence, 
a T1-weighted dual fast gradient-recalled echo sequence, and 
a transverse breath-hold three-dimensional T1-weighted fat-
suppressed spoiled gradient-recalled echo sequence before and 
after dynamic injection of 0.1 mmol per kilogram of body weight 
of non-specific gadolinium chelates, followed by a 20-mL saline 
solution flush at a rate of 2 mL/s administered with a power 
injector. Hepatic arterial-dominant, portal venous, and equilibrium 
phase sequences were performed 20-25 s, 60-70 s, and 180-200 s 
after intravenous contrast material injection, respectively. Oelayed 
phase sequence ( obtained 6-10 min after the administration of 
contrast material) was not part of our systematic protocol and was 
performed in 28 patients with 67 hemangiomas. The other param-
eters are summarized in Table 1. 
2.4. DW MR protocol 
A free-breathing fat-suppressed single-shot echoplanar OW MR 
sequence was performed before contrast material injection in 
the transverse plane with tridirectional diffusion gradients (being 
collinear with the Cartesian axes of the scanner coordinate system) 
to obtain images sensitive to diffusion. Gradient strengths corre-
sponding to b values ofO, 150, and 600 s/mm2 were used with trace 
(average) image assessment. Fat suppression was implemented 
by the spectral presaturation with inversion recovery technique. 
Cardiac gating was not used. No antispasmodic drugs were admin-
istered. An AOC map was generated between T2 echoplanar images 
and the trace image by using the three-point method. The other 
parameters are summarized in Table 1. 
2.5. Image analysis 
The study coordinator (a radiologist with 7 years of experience) 
reviewed ail MR examinations of the study period and collected 
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fable l 
MR sequence parameters. 
Parameter 
Sequence 
Respiratory triggered 
Fat suppression 
Field ofview (cm) 
Matrix (phase x frequency encoding) 
Repetition time (ms) 
Echo time (ms) 
Flip angle (0 ) 
Echo pl anar imaging factor 
Parallel imaging acceleration factor 
Number of signais acquired 
Section thickness (mm) 
Intersection gap (mm) 
Number of sections 
b values (s/mm2 ) 
Acquisition time 
T2-weighted imaging 
Fast spin echo Single-shot 
Yes No 
Yes (SPIR) No 
30-40 X 30-40 30-40 X 30-40 
192x256 192 X 256 
1600-8000 11,351/19,173 
90 85 
90 90 
2 2 
4-5 5 
1-1.5 
32-35 32 
2-3 min 19-23s 
Tl-weighted imaging DW MR imaging Dynamic CE imaging 
Dual fast GRE Echoplanar 30 spoiled GRE 
No No No 
No(IP/OP) Yes (SPIR) Yes (water selection) 
30-40 X 30-40 30-40 X 30-40 30-40 X 30-40 
168 X 256 120 X 256 192x256 
235 3448 3.3-4.7 
2.3/4.6 63 1.4-2.3 
80 90 10 
45-51 
2 2 2 
8 
5 6 4 
1 0.6 -2 
32 32 32 
0, 150, 600 
16-20 s 4-5min 20-25 s 
Note: SPIR =spectral presaturation with inversion recovery, GRE= gradient-recalled echo, IP/OP =in- and opposed-phase, DW = diffusion-weighted, MR = magnetic resonance, 
CE= contrast-enhanced, 30 = three-dimensional. 
imaging findings of patients who fulfilled inclusion criteria. The 
images were evaluated by two radiologists (R.O. and M. R., with 7 
and 10 years of experience). Readers were blinded to clinical infor-
mation including pathological conditions and previous imaging. Ali 
sequences including OW MR images were read in the same session. 
The MR characteristics of hemangiomas were determined in con-
sensus. Lesions which met the imaging criteria of a cyst were not 
evaluated. 
2.6. Ana/ysis of conventional MR images 
The size and location determined according to the Couinaud 
classification were recorded for each patient. The signal intensity of 
ail the hemangiomas was graded on T2-weighted and T1-weighted 
images as isointense, hypointense, or hyperintense in relation to 
normal liver tissue. High signal intensity lesions on T2-weighted 
images were also compared to the spleen and low signal intensity 
lesions on T1-weighted images were compared to the aorta. 
On dynamic contrast-enhanced MR sequences, hemangiomas 
were classified as follows: (i) classical ifhemangioma shows early, 
peripheral, globular, and discontinuous enhancement with pro-
gressive centripetal and prolonged enhancement, (ii) rapidly filling 
if hemangioma shows immediate homogeneous enhancement at 
the arterial phase and iso or hyperintensity compared with sur-
rounding liver parenchyma at the equilibrium phase [7,8]. (iii) 
delayed filling if hemangioma shows a Jack of enhancement in the 
arterial phase with bright-dot enhancement or minimal peripheral 
enhancement in the portal or the equilibrium phase ( 14]. 
Liver steatosis was searched and defined as a decrease in signal 
intensity in the opposed-phase gradient-recalled echo T1-weighted 
MR sequence. 
2.7. Analysis of DW MR images 
Image quality of OW MR images was assessed on a three-point 
scale (good, satisfactory, unsatisfactory). Lesions were analyzed on 
images with a b value of 0, 150, and 600 s/mm2 for signal inten-
sity relative to the liver and presence of T2 shine-through effect. 
The SI of the lesions was graded as isointense, hypointense, or 
hyperintense in relation to liver parenchyma. To reflect clinical 
practice, the presence of T2 shine-through effect was assessed 
qualitatively and T2 shine-through effect was considered present 
when the lesion-to-liver contrast was similar or increased with a 
b value of 600 s/mm2 compared wifh a b value of O s/mm2 , and 
absent if the lesion-to-liver contrast was decreased with a b value 
of 600 s/mm2 compared with a b value of O s/mm2 . ln heteroge-
neous hepatic hemangiomas on OW MR images, a T2 shine-through 
effect was considered present when the lesion-to-liver contrast 
was similar or increased anywhere in the lesion with a b value of 
600s/mm2 . 
AOC values of lesions were obtained from pixel-based AOC 
maps. The software provided by the superconducting MR system 
was used for calculating AOC maps. The largest possible region of 
interest (ROI) was drawn for each tumor in order to encompass 
as much of the lesion as possible (mean surface, 2.4 cm2 ; range, 
0.16-135.4 cm2 ). The RO!s were placed at a level of section on which 
the lesion had its largest diameter. The ROls created on the trace 
images were superimposed on the AOC map. The location of!esions 
that were not visualized on OW images was determined by using 
T2-weighted and/or contrast-enhanced T1-weighted images. Three 
RO!s of atleast 1 cm2 (mean, 1.9 cm2 ; range, 1-2.8 cm2 ) were placed 
in the adjacent normal appearing liverparenchyma in the same lobe 
as the lesion and AOC values were then averaged. ROI placement 
was carefully performed to avoid any adjacent main branch blood 
vessels, the gallbladder, liver periphery, and motion artifacts. 
2.8. Statistical ana/ysis 
Hemangioma characteristics (size, location, signal intensities on 
T2- and Tl-, enhancement patterns, and AOC values) as well as 
liver steatosis were compared between the group ofhemangiomas 
with T2 shine-through effect and the group without. Continuous 
variables were tested by using the Mann-Whitney-Wilcoxon test. 
Fisher's exact test was used in the analysis of contingency tables. 
Multivariate analysis was performed by usingJMP, Version 9.0, SAS 
Institute !ne., Cary, NC. A difference with a P value of Jess than 
.OS was considered statistically significant. In patients with mul-
tiple lesions, the analysis was not performed by using cluster mode 
because it has been previously shown that hemangioma character-
istics may differ in the same pa.tient [ 15 ]. 
3. Results 
3. 1. Qualitative ana/ysis 
The mean size of hemangiomas was 18.8 ± 19.2 mm ranging 
from 5 to 150 mm. Sixty-two hemangiomas were located in the 
left liver lobe (i.e. segment 2 and 3), none in the caudate lobe, 38 
in the segment 4, 107 and 181 in the right anterior (i.e. segment 5 
and 8) and posterior (i.e. segment 6 and 7) segments, respectively. 
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Fig. 2. Presence or absence ofT2 shine-through effect according to the size of the hepatic hemangiomas. 
On fat-suppressed T2-weighted fast spin-echo sequences, 
nearly ail hemangiomas were hyperintense relative to liver and 
to spleen (n =360 (92.8%)) or to liver alone (n = 26 (6.7%)). On 
single-shot T2-weighted sequences, nearly ail hemangiomas were 
hyperintense relative to liver and to spleen (n = 355 (91.5%)) or 
to liver alone (n=25 (6.4%)). Only two (0.5%) and eight (2.1%) 
\1emangiomas were isointense relative to. liver on fat-suppressed 
T2-weighted fast spin-echo and on single-shot T2-weighted 
sequences, respectively. 
On in-phase gradient-recalled echo T1-weighted images, nearly 
ail hemangiomas were hypointense relative to liver and to aorta 
(similar or lower than aorta) (n = 181 (46.6%)) and relative to liver 
alone (n = 200 (51.6%)). Only seven (1.8%) hemangiomas were isoin-
tense relative to liver. On opposed-phase gradient-recalled echo 
T1-weighted images, liver steatosis was present in 29/149 patients 
(19.5%). 
On three-dimensional T1-weighted fat-suppressed spoiled 
gradient-recalled echo contrast-enhanced sequences, hepatic 
hemangiomas had classical enhancement pattern in 266/388 
patients (68.5%), whereas rapidly filling and delayed filling 
enhancement patterns were present in 62/388 patients (16%) and 
60/388 patients ( 15.5%), respectively. 
Ali OW MR images were of diagnostic quality. T2 shine-through 
effect was observed in 204/388 (52.6%) of hepatic hemangiomas 
and in 100 (67.1%) patients. The mean size of hepatic heman-
giomas showing T2 shine-through effect was 22 mm whereas it 
was of 16 mm in lesions that did not exhibitT2 shine-through effect 
(P= .0455). Fig. 2 summarizes the presence or absence ofT2 shine-
through effect according to the size of the hepatic hemangiomas. 
T2 shine-through effect was more frequent in hemangiomas 
in the right liver lobe than in hemangiomas in the left liver lobe 
(n = 179/326 (54.9%) vs n = 25/62 ( 40.3%), P= .0381, respectively). 
No statistical difference was found when comparing hemangiomas 
in the left vs right livers. 
T2 shine-through effect was observed more frequently in 
patients with hemangiomas having hyperintensity similar or supe-
rior to the spleen on fat-suppressed T2-weighted fast spin-echo 
sequences, than in the other patients (197/360 (54.7%) vs 7/28 
(25%), P= .0028, respectively). This was not significant with single-
shot T2-weighted sequences. T2 shine-through effect was more 
frequently observed in patients with hemangiomas having very low 
lesion intensity (similar or lower than aorta) on in-phase gradient-
recalled echo T1-weighted images than in the other patients 
(n = 106/181 (58.6%) vs n = 98/207 ( 47.3%), P= .0249, respectively). 
The presence oftheT2 shine-through effectwas notassociated with 
liver steatosis. 
T2 shine-through effect was observed in classical, rapidly filling, 
and delayed filling hemangiomas in 151 /266 (56.8%) (Figs. 3 and 4), 
15/62 (24.2%), and 36/60 (60%) (Fig. 5), respectively (P< .0001 ail 
together, with significant differences between classical and rapidly 
filling hemangiomas (P< .0001) and between delayed filling and 
rapiclly filling hemangiomas (P< .0001 )) (Fig. 6). 
T2 shine-through effect was more frequent in typical heman-
giomas (defined as lesion signal intensity similar or stronger 
than spleen on both fat-suppressed T2-weighted fast spin-echo 
and single-shot T2-weighted sequences, and classical contrast 
enhancement) than in the others (144/248 (58.1%) vs 60/140 
( 42.9%), P= .0043) (Fig. 7). 
3.2. Quantitative analysis 
The mean AOC value of ail hemangiomas was signifi-
cantly higher than that of the liver (2.17 ± 0.36 x 10-3 mm2 /s 
vs 1.48 ± 0.21 x 10-3 mm2 /s, respectively, P< .0001 ). The mean 
AOC value of hemangiomas in the right liver was significantly 
lower than that in the ]eft Ji Ver (2.12 ± 0.32 X 1 o-3 mm2 /s VS 
2.32 ± 0.42 X 1 o-3 mm2 /s. respectively, P= .0021 ). Mean AOC value 
of hemangiomas showing T2 shine-through effect was signifi-
cantly lower than hemangiomas without T2 shine-through effect 
(2.00 ± 0.48 x 10-3 mm2 /s vs 2.38 ± 0.45 x 10-3 mm2 /s, P< .0001 ). 
Mean AOC value of adjacent liver was significantly lower in 
patients with hemangiomas showing T2 shine-through effect than 
in others (1.44 ± 0.23 x 10-3 mm2 /s vs 1.53 ± 0.32 x 10-3 mm2 /s, 
P = .0214 ). Mean AOC value of the hemangiomas according 
to the classical, rapidly filling and delayed filling enhance-
ment pattern was significantly different (2.17 ± 0.48 x 1 o-3 mm2 /s, 
7 
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Fig. 3. Hepatic hemangioma with classical enhancement pattern in a 55-year-old woman with unknown hepatic lesion on ultrasound. (a) On in-phase gradient-recalled 
echo T1-weighted MR sequence. the hepatic hemangioma appears hypointense (arrow) and (b) on fat-suppressed T2-weighted fast spin-echo MR sequence, the lesion 
is hyperintense relative to surrounding liver and spleen (spleen not shown) (arrow). (c) On DW MR sequence, the lesion-to-liver contrast is similar with ab value of 
600 s/mm2 compared with ab value ofüs/mm2 meaningT2 shine-through effect (arrows). (d) ADC value of the lesion is 1.69 ±0.34 x 10-3 mm2 /s (arrow). (e-g) On dynamic 
contrast-enhanced MR sequences, the lesion•·s·hows early, peripheral, globular: and discontinuous enhancement with progressive centripetal enhancement (arrows). 
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Fig. 4. Hepatic hemangioma with classica! enhancement pattern in a 67-year-old woman with breast cancer. (a) On in-phase gradient-recalled echo Tl-weighted MR 
sequence, the hepatic hemangioma appears hypointense (arrow) and (b) on fat-suppressed T2-weighted fast spin-echo MR sequence, the lesion is hyperintense relative to 
surrounding li ver and spleen {spleen not shown) (arrow). (c) On DW MR sequence, the Jesion-to-liver contrast is decreased with ab value of 600 s/mm2 compared with a 
b value ofüs/mm2 (absence ofT2 shine-through effect) (arrows). (d) AOC value of the lesion is 2.89±0.42x10-3 mm2 /s (arrow). (e-g) On dynamic contrast-enhanced MR 
sequences, the les ion shows early, periphe"ral, globular, and discontinuous enhancement with progressive centripetal enhancement (arrows). 
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Fig, 5. Hepatic hemangioma with delayed enhancement pattern in a 53-year-old woman with unknown hepatic lesion on ultrasound. (a) On in-phase gradient-recalled 
echo Tl-weighted MR sequence, the hepatic hemangioma appears hypointense (arrow) and (b) on fat-suppressed T2-weighted fast spin-echo MR sequence, the lesion is 
hyperintense relative to surrounding liver and spleen (arrow). ( c) On DW MR sequence, the lesion-to-liver contrast is increased with ab value of 600 s/mm2 compared with a 
b value of O s/mm2 (T2 shine-through effect). ( d) AOC value of the les ion is 1.73 ± 0.34 x 1 o-3 mm2 /s (arrow). ( e-g) On dynamic contrast-enhanced MR sequences, the lesion 
shows a Jack of enhancement in the arterial phase (e) with minimal peripheral enhancement in the portal (f) and equilibrium phases (g) (arrows). 
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Fig. 6. Hepatic hemangioma with early enhancement pattern in a 43-year-old man with thyroid cancer. (a) On in-phase gradient-recalled echo Tl-weighted MR sequence, 
the hepatic hemangioma appears hypointense (arrow) and (b) on fat-suppressed T2-weighted fast spin-echo MR sequence, the lesion is hyperintense relative to surrounding 
liver and spleen {spleen partially shown) (arrow). (c) On DW MR sequence, the lesion-to-liver contrast is decreased with ab value of600s/mm2 compared with ab value 
of 0 s/mm2 • ( d) ADC value of the lesion is 2.64 ± 0.38 x 10-3 mm2 /s (arrow). ( e-g) On dynamic contrast-enhanced MR sequences, the les ion shows immediate homogeneous 
enhancement at the arterial phase (e) that persists at the portal phase (f) and equilibrium phase (g) (arrows). 
11 
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Fig. 7. Typical hepatic hemangioma in a 66-year-old woman with intraductal papillary mucinous neoplasm. (a) On in-phase gradient-recalled echo Tl-weighted MR sequence, 
a hepatic hemangioma (dotted arrow) and a cyst (solid arrow) appear hypointense and (b) on fat-suppressed T2-weighted fast spin-echo MR sequence and (c) single-shot 
T2-weighted sequences, these lesions are hyperintense relative to surrounding liver and spleen. (d) On DW MR sequence, the lesion-to-liver contrast is decreased with ab 
value of 600 s/mm2 compared with ab value of 0 s/mm2 for the cyst (solid arrow) but not for the hepatic hemangioma ( dotted arrow) which has an increased lesion-to-liver 
contrast with ab value of 600 s/mm2 (T2 shiné-through effect). (e) AOC value of the hepatic hemangioma is 1.87 ± 0.37 x 10-3 mm2 /s (black dotted arrow). (f-i) On dynamic 
contrast-enhanced MR sequences, the hepatic hemangioma shows early, peripheral, globular, and discontinuous enhancement with progressive centripetal enhancement 
( dotted arrows ). 
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2.44 ± 0.52 x 1 o-3 mm2 /s, 1.98 ± 0.5 x 1 o-3 mm2 /s, respectively, 
P=.0002). 
On multivariate analysis, the only significant factors associ-
ated with T2 shine-through effect were high signal intensity on 
fat-suppressed T2-weighted fast spin-echo images (P= .0119), the 
classical or delayed filling hepatic hemangiomas on contrast-
enhanced sequences (P< .0001) and a low AOC value of the liver 
(P=.0114). 
4. Discussion 
To our knowledge, this is the first study that has evaluated 
the frequency and the associated factors of T2 shine-through 
effect in patients with hepatic hemangiomas. We have shown 
that T2 shine-through effect is approximately observed in half 
of the lesions and in two-thirds of a large patient population 
with hepatic hemangiomas. As persistent hyperintensity compared 
with liver parenchyma at high b values is part of the criteria that 
suggest malignancy, it is important to emphasize this common 
finding in hepatic hemangiomas [ 16]. Presence ofî2 shine-through 
effect was even more common in typical hemangiomas (includ-
ing strong hyperintensity on T2-weighted sequences and classical 
enhancement) than in other hemangiomas. Indeed, specificity of 
MR imaging for the diagnosis of hepatic hemangiomas nearly 
reaches 100% when typical MR features are seen but we want to 
stress the fact that OW MR images should be read concurrently 
with ail available MR sequences to avoid misinterpretation [ 4 ]. AOC 
measurement should be helpful for recognizing T2 shine-through 
effect as lesions that show persistent hyperintensity on high b val-
ues related to this phenomenon have high diffusivity on the AOC 
map and high AOC values. In our series, although mean AOC value 
was significantly lower in hemangiomas showingT2 shine-through 
effect, it was still far above the AOC cutoffs ( 1.4-1.6 x 1 o-3 mm2 /s) 
that have been described in the literature for distinguishing benign 
from malignant liver lesions [ 10]. Yet, in daily routine AOCs may 
not be systematically measured and AOC measurement might be 
problematic in small-sized lesions. 
We have found several factors that have been significantly 
associated with the presence of T2 shine-through effect. The long 
T2-relaxation time observed in the vast majority of hemangiomas 
which is related to the fluid content might explain the high occur-
rence of T2 shine-through effect in our series. As a confirmation, 
T2 shine-through effect was Jess often observed in hemangiomas 
which were notas hyperintense as the spleen on fat-suppressed 
T2-weighted fast spin-echo sequences. 
T2 shine-through effect was significantly more often seen in 
hemangiomas in the right liver lobe than in the left liver lobe and 
the mean AOC value of hemangiomas in the right li ver was signif-
icantly lower than that in the left liver. These differences might be 
attributed to the artifacts caused by cardiac motion predominantly 
observed in the left lobe of the li ver, resulting in higher AOC values 
over the left li ver lobe [ 17· 20 j. 
On multivariate analysis, the pattern of contrast-enhancement 
was a significant factor and T2 shine-through effect was more fre-
quent in classical and delayed filling hemangiomas than in rapidly 
filling hemangiomas. Interestingly, significant differences in AOC 
values according to the enhancement pattern have been previ-
ously shown with the highest mean AOC value in rapidly filling 
hemangiomas, followed by classical and delayed filling heman-
giomas [14]. Hemangiomas are blood-pooled lesions and their 
different enhancement patterns are related to the collective sizes 
of their vascular spaces [ 13 ]. In rapidly filling hemangiomas, con-
trast agent fills-in immediately and completely ail vascular spaces 
reflecting high blood flow velocity and therefore high diffusivity. 
On the contrary, classical and delayed hemangiomas, which are 
usually larger, contain vascular spaces with decreased perfusion 
and extensive scar tissue explaining the lower diffusivity than 
rapidly filling hemangiomas. Hence, we might speculate that 
persistent signal on high b values in some hemangiomas could cor-
respond in part to true T2 shine-through effect favored by long 
T2-relaxation time and in part to differences in diffusivity related 
to contrast-enhancement, which is confirmed by differences in AOC 
values. 
There were several limitations to this study. First, the retrospec-
tive design of our study constituted a classical limitation. However, 
we included patients with hepatic hemangiomas who had MR 
imaging in a consecutive manner in order to limit sampling bias. 
Second, the diagnosis of hepatic hemangiomas was mainly based 
on imaging features and follow-up period and rarely on tissue 
sampling obtained by surgery or biopsy (only eleven lesions were 
histologically confirmed). This is a common limitation with hepatic 
hemangiomas as CT and/or MR imaging are highly reliable for the 
diagnosis of hemangiomas. But if only histopathologically con-
firmed hemangiomas had been taken into account, this would not 
correspond to clinical practice. Third, we did not separate diffusion 
and perfusion by means of a wide range of b values and biexpo-
nentional fitting and we used in our study a three-point method 
to calcula te AOC values with b values of 0, 150, and 600 s/mm2, 
the two-point method being Jess reliable [ 10, 11 ]. Yet, we wanted 
to focus on the visual assessment of OW images. Fourth, we could 
have used higher b values to mitigate the T2 shine-through effect. 
Yet, the highest b value used in our protocol (600s/mm2) reflects 
the current state of the art recommendations (i.e. 500-750 s/mm2) 
in liver OW MR imaging [ l 0,11 j. 
In conclusion, T2 shine-through effect is frequently observed in 
hepatic hemangiomas on high b values OW images, and mostly 
in classical or delayed filling hemangiomas. Radiologists should 
be aware of this phenomenon in order to avoid making an erro-
neous diagnosis of malignancy, particularly when contrast material 
injection is contraindicated. 
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